ch 29717 has been researched along with ergoline in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baschieri, L; Bassetti, M; Beck-Peccoz, P; Faglia, G; Giannattasio, G; Martino, E; Pinchera, A; Sartorio, A; Spada, A; Vallar, L | 1 |
| Markó, M | 1 |
| Bassetti, M; Giannattasio, G; Pezzo, G; Sartorio, A; Spada, A | 1 |
| Besser, GM; Delitala, G; Grossman, A; Hathway, NR; Yeo, T | 1 |
4 other study(ies) available for ch 29717 and ergoline
| Article | Year |
|---|---|
In vitro studies on TSH secretion and adenylate cyclase activity in a human TSH-secreting pituitary adenoma. Effects of somatostatin and dopamine.
Topics: Adenoma; Adenylyl Cyclases; Dopamine; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Hyperthyroidism; In Vitro Techniques; Middle Aged; Pituitary Neoplasms; Radioimmunoassay; Somatostatin; Thyrotropin | 1985 |
Dopamine agonistic potency of two novel prolactin release-inhibiting ergolines.
Topics: Animals; Cells, Cultured; Dopamine; Ergolines; Male; Pituitary Gland; Prolactin; Rats; Rats, Inbred Strains | 1984 |
In vitro effect of dopamine on growth hormone (GH) release from human GH-secreting pituitary adenomas.
Topics: Adenoma; Cells, Cultured; Dopamine; Dose-Response Relationship, Drug; Ergolines; Female; Growth Hormone; Humans; Male; Pituitary Neoplasms; Prolactin | 1982 |
Two new dopamine agonists that are long acting in vivo but short acting in vitro.
Topics: Animals; Bromocriptine; Dose-Response Relationship, Drug; Ergolines; In Vitro Techniques; Male; Pergolide; Prolactin; Rats; Secretory Rate; Time Factors | 1980 |